| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales > How to Eliminate Objections to Price |
|
Subjects - How to Eliminate Objections to Price
Have you ever stepped your way through the sales process
only to be disappointed by your prospect's objection to
your price? This situation unfolds all too regularly for ma According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ny small
business owners. The other day I was talking to Joan who was lamenting how she’d spent a ton of time developing a relationship with a new prospect, but in the e ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in nd wasn’t able to make the sale.
Over the course of six sales meetings her prospect seemed
like a slam dunk. He was very enthusiastic about her
product (inventory con lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. trol software for the food service
industry), he hadn’t seen a similar product on the market
(Joan’s software has a unique and easy to use interface) and
he and Joan se here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe emed to have a great rapport (they both are
avid snow boarders and each loves jazz) . But when it came
time for Joan to ask for the business the answer was ‘no’.
Her h d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t prospect was cool on her price. Where did Joan go wrong? She was quite befuddled with her collapsed deal and wanted to know what she could do to prevent such future fa ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ilings. Not only did she not get the
business, she ended up wasting her valuable time which could
have been better spent developing a lead that turned into a
sale. Doe easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s this sound familiar? Have you ever spent time
developing a great lead only to have the deal fall apart
because your prospect objects to your price? If so, you may have nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically made the same common sales mistake Joan
made: she tried to make the sale without having enough
information to make her prospect the right offer, despite
her six positiv and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e sales meetings. What Joan neglected to do was to ask her prospect about his accounting needs with respect to inventory control. Unfortunately for Joan, she learned thi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi important fact only
after our conversation when she called her prospect back to
find out where she went wrong. Her prospect had already
decided to use the software of ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a one of her competitors. Even
though Joan’s software features a nice accounting package,
her offer included nothing with respect to accounting. Her
prospect assumed tha dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t her software didn’t feature the
accounting functionality he required because Joan didn’t
mention it. She talked a lot about the software’s
innovative, easy to use int cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin erface and its great database
functionality but she never mentioned the accounting
features because her prospect didn’t ask. Her price would
have been fine if her prosp tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ect had known about the
accounting capability of her software! During your sales process be sure to ask all the questions you need answered to understand your prospect’s t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel eeds. You
can then use the information you’ve acquired to shape your
pitch around exactly what is going to solve your prospect’s
problems. Before you tell your prospec ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t your price make sure the time
is right by asking questions like: · Does this sound helpful? · Is there anything I haven’t mentioned that would be helpful? · What do you y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products like best about our competition’s product or service? By obtaining answers to these questions you will be able to gauge whether or not you have enough information to make . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de an
offer that your prospect would be ill-advised to decline. If you don’t have enough information go back for more; schedule another meeting and then go through another p elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip robing
round of questions. If you do have enough information, make your prospect the best offer they’ve ever heard. If you’ve done enough homework you’ll make the sale tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Advertising's Compound Interest The Keys to Delivering World-Class Service
|